GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use from birth.

Recombinant hepatitis B vaccine

Adult formulation

Each 1.0 mL monodose vial or pre-filled syringe contains:

  • 20 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium as aluminium hydroxide

Paediatric formulation

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 10 µg HBsAg protein, adsorbed onto 0.25 mg aluminium as aluminium hydroxide

Both formulations may contain yeast proteins.

For full details, refer to the product information and consumer medicine information sheets for Engerix-B vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


hepatitis B surface antigen